- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03749161
Low-add Multifocal vs. Monofocal IOLs
Comparison Between Bilateral Low-add Multifocal Intraocular Lenses and Monofocal Intraocular Lenses: A Randomised Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Spectacle independence is one of the main aims in modern cataract surgery. Although bilateral monofocal IOL implantation, aiming for emmetropia or low myopia, leads to high levels of patient satisfaction in distance vision, spectacle dependence for intermediate vision, reading and other near vision tasks is the usual result.
There are different techniques to reduce spectacle dependence, the most common one is the use of multifocal IOLs. However, a variable number of patients complain of problems, such as glare or haloes (positive dysphotopsia symptoms). Dysphotopsia symptoms may vary significantly from patient to patient. The real incidence of dysphotopsia like symptoms after cataract surgery and multifocal IOL is unknown and the implantation of multifocal IOLs is a commonly accepted contraindication in patients who are night drivers. Another characteristic of many multifocal IOLs is that it can provide patients with excellent near and distance vision but lack in the intermediate range.
One option to enhance intermediate vision and to leave patients with good contrast sensitivity is the use of low-add multifocal IOLs. These IOLs are adequate to expectations a lot of patients have, who were used to have a good distance vision and who were wearing spectacles when performing near vision tasks before surgery. Many of these patients would prefer to keep their reading spectacles after surgery and ideally would like to function well at distance and intermediate (60 to 80 cm - computer distance, household work…) range without glasses.
One example of these low-add multifocal IOLs is the LENTIS Comfort MF15 with a near add of 1.50D (on IOL plane). Its single, blended transition zone works to deliver patients the same kind of distance vision as a monofocal IOL with the addition of enhanced intermediate vision. In particular, this design provides improved vision at a distance of 60 cm and more. Additional key features of the Comfort IOL include good contrast sensitivity for twilight vision, optimized depth of focus, and natural imaging quality and color sensitivity. Especially this type of IOL may lead to more tolerance of postoperative refractive errors due to biometry and IOL power calculation imprecision. This should result in better unaided distance vision and therefore higher patient satisfaction after cataract surgery.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1140
- Recruiting
- Vienna Institute for Research in Ocular Surgery (VIROS)
-
Contact:
- John Falasinnu, MD
- Phone Number: 01 / 91021 / 57559
- Email: office@viros.at
-
Contact:
- Nino Hirnschall, MD
- Phone Number: 01 / 91021 / 57562
- Email: office@viros.at
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age-related cataract in both eyes
- Scheduled for bilateral cataract surgery
- Motivated to be less spectacle dependant in the distance to intermediate vision range
- Patients with an expected BCDVA of 0.8 snellen score or better after surgery
- Patients with the need of an IOL Power in the range of 10 to 30D (biometry performed with the IOL master 700)
- Age 21 and older
- Written informed consent prior to recruitment
Exclusion Criteria:
- Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
- Retinopathia pigmentosa
- Chronic uveitis
- Amblyopia
- Pupil decentration > 1mm center shift
- preceded retinal surgery
- preceded Laser-in-situ-Keratomileusis (LASIK)
- Any ophthalmic abnormality that could compromise visual function or the measurements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Lentis comfort
Patient will receive the low-add multifocal IOL during cataract surgery
|
Lentis comfort, low-add multifocal, IOL
|
|
EXPERIMENTAL: Lentis L-313
Patient will receive the monofocal IOL Lentis L-313 during cataract surgery
|
Lentis L-313, monofocal IOL
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spectacle independence questionnaire
Time Frame: 12 months
|
Spectacle independence will be assessed using a questionnaire.
In this questionnaire the patient will be asked about usage of spectacles for far, near and intermediate distance.
Best result will be if the patient is independent from any spectacles in the different distances.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Best Corrected Distance Visual Acuity and Uncorrected Intermediate Visual Acuity
Time Frame: 12 months
|
Best corrected distance and uncorrected intermediate visual acuity will be assessed using the ETDRS charts
|
12 months
|
|
Titmus Fly Stereo test
Time Frame: 12 months
|
Stereo Vision assessment will be done using the Titmus Fly Stereo test.
The patients will be asked to detect stereoscopic objects of different difficulty levels.
The result will be better, the more correct stereoscopic objects the patient will detect.
|
12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Oculentis
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Colvard Kandavel Eye CenterEnrolling by invitationCataract | Cataract Bilateral | Cataract Surgery | Cataract (Post-operative Cataract Surgery Follow-up)United States
-
Matthew RauenNot yet recruitingNuclear Cataract | Cataract Surgery Anesthesia | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Züleyha SönmezAtaturk UniversityActive, not recruitingCataract Surgery | Cataract Patients | Cataract After SurgeryTurkey (Türkiye)
-
Stanford UniversityEnrolling by invitationIntraocular Lens | Cataract Extraction | Cataract Surgery | Eye Disorders | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Seva Canada SocietyPragyaan Sustainable Health Outcomes Foundation; Sadgura Netra ChikitsalayaNot yet recruitingCataract (Post-operative Cataract Surgery Follow-up)
-
Nicole Fram M.D.RecruitingCataract Bilateral | Nuclear Sclerosis of the Lens | Phacoemulsification Cataract SurgeryUnited States
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
Clinical Trials on Low-add multifocal IOL
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Ohio State UniversityNational Eye Institute (NEI); University of HoustonCompleted
-
Hospital Oftalmologico de BrasiliaFederal University of Minas GeraisCompleted
-
Mark Packer, MD, FACSAbbott Medical OpticsCompleted
-
Medicontur Medical Engineering LtdCompleted
-
Medicontur Medical Engineering LtdEnrolling by invitation
-
Alcon ResearchWithdrawnVisual OutcomesUnited States
-
Hospital Oftalmologico de BrasiliaCompleted
-
Dell Laser ConsultantsAbbott Medical OpticsUnknown
-
Bausch & Lomb IncorporatedCompleted